Based on the safety of low-dose IL-2 in autoimmune diseases and its regulatory effects on T cells, we applied it over-the-counter to PD-1/PD-L1 inhibitor for treating BP and achieved good efficacy. Here, CD274 is linked to autoimmune disease.